APA

Blessing E., Campbell L. A., Rosenfeld M. E., Chesebro B. & Kuo C. (20050915). A 6 week course of azithromycin treatment has no beneficial effect on atherosclerotic lesion development in apolipoprotein E-deficient mice chronically infected with Chlamydia pneumoniae. : The Journal of antimicrobial chemotherapy.

Chicago

Blessing E, Campbell L A, Rosenfeld M E, Chesebro B and Kuo C-C. 20050915. A 6 week course of azithromycin treatment has no beneficial effect on atherosclerotic lesion development in apolipoprotein E-deficient mice chronically infected with Chlamydia pneumoniae. : The Journal of antimicrobial chemotherapy.

Harvard

Blessing E., Campbell L. A., Rosenfeld M. E., Chesebro B. and Kuo C. (20050915). A 6 week course of azithromycin treatment has no beneficial effect on atherosclerotic lesion development in apolipoprotein E-deficient mice chronically infected with Chlamydia pneumoniae. : The Journal of antimicrobial chemotherapy.

MLA

Blessing E, Campbell L A, Rosenfeld M E, Chesebro B and Kuo C-C. A 6 week course of azithromycin treatment has no beneficial effect on atherosclerotic lesion development in apolipoprotein E-deficient mice chronically infected with Chlamydia pneumoniae. : The Journal of antimicrobial chemotherapy. 20050915.